Form 8-K - Current report:
SEC Accession No. 0001193125-22-301902
Filing Date
2022-12-09
Accepted
2022-12-09 17:27:05
Documents
18
Period of Report
2022-12-09
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d435484d8k.htm   iXBRL 8-K 30715
2 EX-1.1 d435484dex11.htm EX-1.1 205833
3 EX-5.1 d435484dex51.htm EX-5.1 12547
4 EX-99.1 d435484dex991.htm EX-99.1 7713
8 GRAPHIC g435484dsp41.jpg GRAPHIC 4461
9 GRAPHIC g435484dsp42.jpg GRAPHIC 3706
10 GRAPHIC g435484g1209112804335.jpg GRAPHIC 5747
  Complete submission text file 0001193125-22-301902.txt   468437

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA eras-20221209.xsd EX-101.SCH 2836
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE eras-20221209_lab.xml EX-101.LAB 18738
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eras-20221209_pre.xml EX-101.PRE 11698
12 EXTRACTED XBRL INSTANCE DOCUMENT d435484d8k_htm.xml XML 3460
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40602 | Film No.: 221455715
SIC: 2834 Pharmaceutical Preparations